Quotes 5-day view Delayed Nasdaq
01/21/2021
01/22/2021
01/25/2021
01/26/2021
01/27/2021
Date
8.51(c)
8.78(c)
12.96(c)
12(c)
14.995(c)
Last
176 850
753 942
3 176 062
2 316 429
4 522 091
Volume
-1.28% +3.17% +47.61% -7.41% +24.96% Change
Sales 2020
11,2 M - -
Net income 2020
-77,6 M - -
Net Debt 2020
70,2 M - -
P/E ratio 2020
-10,8x
Yield 2020
-
Sales 2021
22,5 M - -
Net income 2021
-74,3 M - -
Net Debt 2021
52,6 M - -
P/E ratio 2021
-12,1x
Yield 2021
-
Capitalization
855 M 855 M -
EV / Sales 2020
82,6x
EV / Sales 2021
40,4x
Nbr of Employees
275
Free-Float
59,5%
Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic technology to conduct antibiotic susceptibility testing (AST), which determines whether live...
Notations Surperformance© of Accelerate Diagnostics, Inc.
Trading Rating : Investor Rating : -
All news about ACCELERATE DIAGNOSTICS, INC.
03:51a ACCELERATE DIAGNOSTICS : Files For Up to $150 Million Mixed ShelfMT
01/13 ACCELERATE DIAGNOSTICS, INC : Results of Operations and Financial Condition, Reg..AQ
2020 ACCELERATE DIAGNOSTICS, INC : Entry into a Material Definitive Agreement, Unregi..AQ
2020 ACCELERATE DIAGNOSTICS : Live at Saint Mary's Regional Health SystemPU
2020 ACCELERATE DIAGNOSTICS, INC : Results of Operations and Financial Condition, Fin..AQ
2020 ACCELERATE DIAGNOSTICS : Management's Discussion and Analysis of Financial Condi..AQ
2020 ACCELERATE DIAGNOSTICS, INC : Results of Operations and Financial Condition, Fin..AQ
2020 ACCELERATE DIAGNOSTICS : 3Q Earnings SnapshotAQ
2020 Earnings Flash (AXDX) ACCELERATE DIAGNOSTICS Posts Q3 Revenue $3.6M MT
2020 ACCELERATE DIAGNOSTICS, INC : Amendment or Waiver to Code of Ethics (form 8-K)AQ
2020 ACCELERATE DIAGNOSTICS : Announcing New FDA Clearance for Accelerate PhenoTest® ..PU
2020 ACCELERATE DIAGNOSTICS, INC : Other Events, Financial Statements and Exhibits (f..AQ
2020 ACCELERATE DIAGNOSTICS : Management's Discussion and Analysis of Financial Condi..AQ
2020 ACCELERATE DIAGNOSTICS : 2Q Earnings SnapshotAQ
2020 ACCELERATE DIAGNOSTICS, INC : Change in Directors or Principal Officers (form 8-..AQ
News in other languages on ACCELERATE DIAGNOSTICS, INC.
- No features available -
Chart ACCELERATE DIAGNOSTICS, INC.
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends ACCELERATE DIAGNOSTICS, INC.
Short Term Mid-Term Long Term Trends Bullish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
5
Average target price
12,33 $
Last Close Price
15,00 $
Spread / Highest target
13,4%
Spread / Average Target
-17,8%
Spread / Lowest Target
-46,6%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
